250 related articles for article (PubMed ID: 10465259)
1. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
[TBL] [Abstract][Full Text] [Related]
2. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
[TBL] [Abstract][Full Text] [Related]
3. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
[TBL] [Abstract][Full Text] [Related]
4. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
[TBL] [Abstract][Full Text] [Related]
5. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
[TBL] [Abstract][Full Text] [Related]
6. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
[TBL] [Abstract][Full Text] [Related]
7. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
Cataldo L; Chen NY; Yuan Q; Li W; Ramamoorthy P; Wagner TE; Sticca RP; Chen WY
Int J Oncol; 2000 Dec; 17(6):1179-85. PubMed ID: 11078803
[TBL] [Abstract][Full Text] [Related]
10. The 20kDa and 22kDa forms of human growth hormone (hGH) exhibit different intracellular signalling profiles and properties.
Yao-Xia L; Jing-Yan C; Xia-Lian T; Ping C; Min Z
Gen Comp Endocrinol; 2017 Jul; 248():49-54. PubMed ID: 28427901
[TBL] [Abstract][Full Text] [Related]
11. The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA.
Wada M; Ikeda M; Takahashi Y; Asada N; Chang KT; Takahashi M; Honjo M
Mol Cell Endocrinol; 1997 Oct; 133(2):99-107. PubMed ID: 9406855
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
13. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor.
Kaulsay KK; Zhu T; Bennett W; Lee KO; Lobie PE
Endocrinology; 2001 Feb; 142(2):767-77. PubMed ID: 11159849
[TBL] [Abstract][Full Text] [Related]
14. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
[TBL] [Abstract][Full Text] [Related]
15. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20K hGH.
Asada N; Takahashi Y; Wada M; Naito N; Uchida H; Ikeda M; Honjo M
Mol Cell Endocrinol; 2000 Apr; 162(1-2):121-9. PubMed ID: 10854705
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
17. Inverse effects of 20K and 22K human growth hormones on the growth of T-47D human breast cancer cells in culture and in nude mice.
Fujikawa T; Kaneko H; Hibasami H; Sakaguchi K; Alam KS; Tanaka M; Nakashima K
Biochem Mol Biol Int; 1998 Nov; 46(4):719-24. PubMed ID: 9844732
[TBL] [Abstract][Full Text] [Related]
18. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
19. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone.
Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE
Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH.
Hayakawa M; Shimazaki Y; Tsushima T; Kato Y; Takano K; Chihara K; Shimatsu A; Irie M
J Clin Endocrinol Metab; 2004 Apr; 89(4):1562-71. PubMed ID: 15070913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
